HIV Treatment and Medical Care

HIV Drugs In Development

The Latest

three arrows

What’s Happening With New HIV Treatments? Three Big Areas to Watch

There’s a lot happening in the field of new HIV treatments. Here’s an overview of the major developments and where the research for each stands.

By Michael Broder
News Analysis

There Is No HIV Vaccine Yet. But New Research Findings Could Bring Us One Step Closer

Movement by the research community towards an HIV vaccine is good news. Here's what the latest trial results mean, and what they do not.

By Larry Buhl
prescription heap

HIV Drugs in Clinical Trials to Treat COVID-19—What You Need to Know

While it may be months or years before effective treatments emerge, the HIV research of the past few decades has given us a head start.

By Michael Broder
Screenshot from Carl Dieffenbach and Anne Rancourt Final IAS 2019 Video
News Analysis

Updates on HIV Treatment Advances and Other Notes From IAS 2019

NIAID's Carl Dieffenbach, Ph.D., joins Anne Rancourt to discuss some key takeaways from the 10th International AIDS Society Conference on HIV Science.

An Overview of Valproic Acid Img

An Overview of Valproic Acid

Other Names: Depakene, Depakote, Depakote ER, Epival, VPA, divalproex sodium, valproate Drug Class: Latency-Reversing Agents Molecular Formula: C8 H16 O2 Registry Number: 99-66-1 (CAS) Chemical Name: 2-propylpentanoic acid Chemical Class: O...

By HIVinfo
An Overview of Trogarzo (Ibalizumab-Uiyk) Img

An Overview of Trogarzo (Ibalizumab-Uiyk)

Brand Name: Trogarzo Other Name(s): Hu5A8, IBA, Ibalizumab-uiyk, TMB-355, TNX-355 Drug Class: Post-attachment Inhibitor Company: TaiMed Biologics USA Corp.

WARNING:Ibalizumab can cause serious, life-threatening side effects, including changes in you...

By HIVinfo
An Overview of Elvucitabine Img

An Overview of Elvucitabine

Other Names: ACH-126443, ELV, L-F-D4C, beta-L-Fd4C, l(-)Fd4C Drug Class: Nucleoside Reverse Transcriptase Inhibitors Molecular Formula: C9 H10 F N3 O3 Registry Number: 181785-84-2 (CAS) Chemical Name: 4-amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,...

By HIVinfo
What Is a Therapeutic HIV Vaccine? Img

What Is a Therapeutic HIV Vaccine?

Unlike a preventive HIV vaccine, a therapeutic HIV vaccine is designed to improve the body's immune response to HIV in people who are already infected with the virus. In the future, these vaccines could eliminate HIV from the body, or improve the bod...

By HIVinfo
PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input Img

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input

Last fall, community activists voiced concerns over the roll out of studies on Descovy (TAF/FTC) as pre-exposure prophylaxis (PrEP) without adequately involving community advisors.

By Jennifer Johnson Avril
Joseph Eron, Jr., M.D., presents 96-week study data from LATTE-2, at IAS 2017 (Credit: Warren Tong)

Long-Acting Injectable HIV Treatment Moves Closer to Reality

Long-acting injectable treatment takes another step closer to being a real-world option for people living with HIV, with new study results presented at IAS 2017.

By Warren Tong